E-LIB Suche - Ergebnisse für: Dalhoff, A.

1

Bewertungskriterien für Antibiotika

Infektiologisches Kolloquium ; 5

Dalhoff, A ; Thomas, H - Reprint 2019 . , [1987]

Link: https://doi.org/10.1515/..

2

Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofl..:

Dalhoff, A. ; Schubert, S. ; Vente, A.
Antimicrobial Agents and Chemotherapy. 61 (2017) 5 - p. , 2017

Link: https://doi.org/10.1128/..

3

Analysis of effects of MCB3681, the antibacterially active ..:

Dalhoff, A. ; Rashid, M.-U. ; Kapsner, T....
Clinical Microbiology and Infection. 21 (2015) 8 - p. 767.e1-767.e4 , 2015

Link: https://doi.org/10.1016/..

4

Antiviral, antifungal, and antiparasitic activities of fluo..:

Dalhoff, A.
European Journal of Clinical Microbiology & Infectious Diseases. 34 (2014) 4 - p. 661-668 , 2014

Link: https://doi.org/10.1007/..

5

Resistance surveillance studies: a multifaceted problem—the..:

Dalhoff, A.
Infection. 40 (2012) 3 - p. 239-262 , 2012

Link: https://doi.org/10.1007/..

6

German multicentre survey of the antibiotic susceptibility ..:

Seifert, H. ; Dalhoff, A. ; on behalf of the PRISMA Study Group
Journal of Antimicrobial Chemotherapy. 65 (2010) 11 - p. 2405-2410 , 2010

Link: https://doi.org/10.1093/..

7

A Long Journey from Minimum Inhibitory Concentration Testin..:

Dalhoff, A. ; Ambrose, P. G. ; Mouton, J. W.
Infection. 37 (2009) 4 - p. 296-305 , 2009

Link: https://doi.org/10.1007/..

8

Bioverfügbarkeit von Chemotherapeutika bei hochvolumiger Fl..:

Dalhoff, A. ; Koeppe, P. ; Hulla, F.
DMW - Deutsche Medizinische Wochenschrift. 106 (2009) 51/52 - p. 1754-1756 , 2009

Link: https://doi.org/10.1055/..

9

The Integrated Use of Pharmacokinetic and Pharmacodynamic M..:

Stass, H. ; Dalhoff, A.
Infection. 33 (2005) S2 - p. 29-35 , 2005

Link: https://doi.org/10.1007/..

10

Immunomodulatory Activities of Fluoroquinolones:

Dalhoff, A.
Infection. 33 (2005) S2 - p. 55-70 , 2005

Link: https://doi.org/10.1007/..

11

Pharmacokinetic/Pharmacodynamic (PK/PD) Evaluation of a Onc..:

Schuck, E. L. ; Dalhoff, A. ; Stass, H..
Infection. 33 (2005) S2 - p. 22-28 , 2005

Link: https://doi.org/10.1007/..

12

Kinetics and Quantification of Antibacterial Effects of Bet..:

Schaper, K.-J. ; Schubert, S. ; Dalhoff, A.
Infection. 33 (2005) S2 - p. 3-14 , 2005

Link: https://doi.org/10.1007/..

13

Effect of pH on the in Vitro Activity of and Propensity for..:

Dalhoff, A. ; Schubert, S. ; Ullmann, U.
Infection. 33 (2005) S2 - p. 36-43 , 2005

Link: https://doi.org/10.1007/..

14

Pharmacodynamics of Moxifloxacin and Levofloxacin Simulatin..:

Schubert, S. ; Dalhoff, A. ; Stass, H..
Infection. 33 (2005) S2 - p. 15-21 , 2005

Link: https://doi.org/10.1007/..

15

Contribution of Immunocompetence to the Antibacterial Activ..:

Dalhoff, A.
Infection. 33 (2005) S2 - p. 44-49 , 2005

Link: https://doi.org/10.1007/..